Opendata, web and dolomites

MOBIUS SIGNED

MØBIUS: Transforming medication management for improved patient safety

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MOBIUS project word cloud

Explore the words cloud of the MOBIUS project. It provides you a very rough idea of what is the project "MOBIUS" about.

intends    market    electronic    company    implementable    loops    iceland    health    first    enhanced    unused    oslash    bius    wasting    drugs    software    drug    security    fraction    dramatically    robots    traceability       strategy    prescriptions    platform    solutions    commercial    excellence    saves    jobs    cumulative    manual    dispensation    brings    integrates    finalizing    pharmaceuticals    entire    commercialization    expenditures    inst    hospital    investment    exchange    seal    countries    medicine    2021    q1    medicines    prescription    improves    stock    removes    business    time    automated    patient    winning    services    designed    pharmacies    validating    transform    safety    oecd    realistic    accountability    ensures    13    flow    plan    automation    data    95    entry    eliminating    dispensing    sme    healthcare    companies    integration    search    22    submission    improvement    facilities    roi    proposition    medication    solution    20    inefficiencies    linking    class    logistics    thula    reduces    sufficient    packaging    integrating    generate    waste    mission    errors    award   

Project "MOBIUS" data sheet

The following table provides information about the project.

Coordinator
THULA-NORRAENT HUGVIT EHF 

Organization address
address: GLERARGOTU 28
city: AKUREYRI
postcode: 600
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Iceland [IS]
 Project website http://thula.is
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2018-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THULA-NORRAENT HUGVIT EHF IS (AKUREYRI) coordinator 50˙000.00

Map

 Project objective

Thula is an award-winning IT company based in Iceland with the mission of providing first class e-health solutions for medication management, logistics and electronic exchange of healthcare information. Thula has developed MØBIUS, a unique software solution that can manage the entire medication flow of hospital pharmacies, long-term healthcare facilities or companies providing healthcare services and logistics. Pharmaceuticals account for 20% of overall healthcare expenditures in OECD countries but a significant fraction of this investment could be reduced by eliminating inefficiencies in drug management (e.g., errors in prescription and dispensation; waste of unused medicines). MØBIUS is an integration platform designed to transform medicine management through enhanced automation. By linking different systems in the medication- and logistics loops, MØBIUS dramatically reduces inefficiencies in stock management and increases patient safety and security. MØBIUS integrates Electronic Prescriptions, automated dispensing robots and distribution systems. It also ensures availability of sufficient drugs for the patient, processes drug dispensing effectively, removes time wasting, saves resources, allows easy access to medicine, brings on more security on the data compared to manual-based systems, and improves accountability and traceability. The objectives of the SME Inst project include finalizing and validating the development of MØBIUS by integrating and packaging advanced features; search of commercial partners in target EU countries; in-depth assessment of entry strategy into the EU healthcare market; and a realistic and implementable business plan. We expect MØBIUS will generate about 40 new jobs and a cumulative ROI of €5.95 in the first 4 years after commercialization in Q1 2021. This submission, an improvement of a previous call in which we achieved a Seal of Excellence (13.22), intends to further demonstrate MØBIUS’ approach and our company’s value proposition.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOBIUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOBIUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More  

Preemie (2019)

Personalised nutrition of low-birth-weight infants

Read More  

Plasmanorg (2019)

Environmental-friendly organic chemical synthesis in plasma reactor

Read More